"Designing Growth Strategies is in our DNA"
The global prefilled syringes market size stood at USD 4.76 billion in 2019 and is projected to reach USD 10.57 billion by 2026, exhibiting a CAGR of 10.5% during the forecast period.
Rising incidence of chronic diseases, such as diabetes and other autoimmune diseases is likely to fuel the demand of the market in the forthcoming years. For instance, according to the American Autoimmune Related Diseases Association Inc. (AARDA), about 50 million Americans suffer from autoimmune disorders currently. Growing demand for biological drugs and innovations in prefillable syringe technologies to fulfill the unmet needs for the treatment of chronic disease across the globe is likely to support the global market growth. Combined with this, the growing number of product launches by key players and increasing adoption of the products by healthcare providers are factors likely to boost the market during the forecast period.
Prefilled syringes are injectable drug delivery containers designed to administer drugs via the parenteral route. Pharmaceutical companies are considering them as one of the most effective ways of delivering a wide range of injectable drugs including biologics and biosimilar. This is the major factor contributing to the demand for prefillable syringes. They enable easy and quick delivery of drugs in case of emergencies.
High Demand for Prefilled Syringes in COVID-19 Vaccines
The impact of the COVID-19 on pharmaceutical packaging is expected to be more pronounced due to the rapid production of vaccines for the coronavirus. There is an increasing demand for these syringes over the glass ampoules or any other additional needles because of the reduced risk of needle-stick injuries. Therefore, in order to ramp up the production of the COVID-19 vaccine, the manufacturers are increasing their production capacity. For instance, the US government has signed a deal of $138 million with the makers of the syringe in order to facilitate the production of 100 million prefilled syringes for the coronavirus vaccines by the end of 2020 and more than 500 million in 2021.
The COVID-19 outbreak has positively impacted the demand for prefilled syringes. The global market is projected to grow by 10.6% in 2020 due to the COVID-19 crisis, as compared to 10.3% without COVID-19.
Request a Free sample to learn more about this report.
Rising Demand for Biologics & Biosimilars to Aid Market Expansion
The global life science industry is facing a drastic shift from chemical-based drugs to biologics and biosimilars. Biologics are excellent for targeted delivery and are less prone to drug-drug interaction, which is leading to its increased inclination. The rise in biologics for the treatment of chronic diseases has urged drug and packaging manufacturers to seek more sophisticated container closure and drug delivery systems. Therefore, this has led to a significant increase in prefillable syringes for delivering the biologics and biosimilars safely. For instance, according to CDSCO, a total of 98 biosimilars have been approved in India till date. In 2018, 42 biologics and 18 biosimilars were approved in India.
Growing Innovations in Prefilled Syringes for Biologic Drugs to Propel the Market Growth
Increasing demand for biological drugs and growing innovations in injectable delivery solutions are likely to drive the global prefilled syringes market growth during the forecast period. Biological drugs have attracted the attention of leading players as they target diseases that had no or very limited treatment options available such as several types of cancer, autoimmune diseases, and other non-communicable diseases. For instance, in March 2019, W. L. Gore & Associates, Inc. launched GORE ImproJect Plunger for these syringes, a solution for silicon-sensitive biologics.
Rising prevalence of cancer, autoimmune diseases, and other non-communicable diseases is likely to increase the demand for biological drugs. For instance, according to the National Cancer Institute, an estimated 1,735,530 new cancer cases were diagnosed in the U.S. in 2018. This number is expected to rise to 23.6 million by 2030, leading to an increase in demand for biologics in the U.S. in 2018.
Rising Adoption of Self-Injecting Parenteral Devices to Spur the Market Growth
The use of prefilled syringes as a self-injecting device is the modern way to administer parenteral drugs. These are convenient and help ease the administration process. They provide greater patient safety by reducing the potential for inadvertent needle sticks and exposure to toxic products that can occur while drawing medications from vials. These syringes with their pre measured dosage, reduce dosing errors and increase patient compliance. Hence, the above reasons are contributing in increasing the adoption and inclination towards this product among both healthcare professionals and patients.
Complex Manufacturing Process and Product Recalls of Prefilled Syringes to Hamper the Market Growth
Prefilled syringes are becoming an increasingly attractive option for complex biotechnology products. However, various product recalls owing to the presence of certain impurities or leakage in the syringes are responsible for restricting the market growth during the forecast period. For instance, in April 2020, BD announced a voluntary, consumer-level medical device recall of multiple lots of Recall of PosiFlush SF Saline Flush Syringe because of the holes in the packaging.
Rise in Technological Innovations to Drive Plastic Segment Growth
Based on material, the market is classified into glass and plastic. Among them, the glass segment held the largest market share in the year 2019. Glass has strong barrier properties which make it preferred material for the manufacturing of this type of syringes. Additionally, glass is highly compatible with different filling drug machines. However, certain concerns over glass quality such as breakage issues and the reaction of glass ions with the drugs are likely to shift the preference from glass to plastic.
The plastic segment is anticipated to be the fastest-growing segment during the forecast period owing to the presence of key players involved in developing plastic syringes and growing technological innovations offering advantages over glass syringes. For instance, in July 2017, Gerresheimer AG announced to expand its product portfolio of plastic prefilled syringes through an exclusive license from West Pharmaceuticals Services, Inc.
Luer Lock Form System to Exhibit Significant Growth Rate in the Market
Based on the closing system, this market has been segmented into a staked needle system, Luer cone system, and Luer lock form system. Among them, the staked needle system segment captured a major share in the market owing to the speedy usage of the staked needle system. However, the rising incidence of needle stick injuries is likely to reduce the growth rate of the staked needle system segment in the coming years.
Technological advancements in the Luer lock form systems are making them more secure by preventing needle stick accidents. Moreover, the twisting mechanism forming a locked connection in the Luer lock form system has reduced the leakage of liquid drugs, further augmenting the segment growth at a faster pace during the forecast period. For instance, in March 2019, Gerresheimer AG showcased metal-free 1 ml long luer lock Gx RTF glass syringes for bioengineered active substances at PDA annual meeting in San Diego.
Complete Syringe Set to Hold Lion’s Share in Prefilled Syringes Market
Based on the product, the market has been segmented into complete syringe set and components & accessories. Among them, the complete syringe set segment captured a major portion of the market share owing to the growing demand for these products for effective drug delivery and rising demand for self-injectable delivery system among patients. The components & accessories segment is expected to register moderate growth in the market in the forthcoming years. This is attributed to the lower demand among drug manufacturing companies for independent components for these syringes in comparison to the complete set.
To know how our report can help streamline your business, Speak to Analyst
Single Chamber Segment to Capture the Largest Market Share
Based on the design, the market has been segmented into a single chamber, double- chamber, and multiple chambers syringes. Among them, the single-chamber segment captured a major share of the market and is likely to exhibit a significant CAGR during the forecast period.
Growing technological innovations and shifts in preference from a single chamber prefilled syringe to the dual-chamber system are likely to enhance the demand for the double-chamber system during the forecast period. Double-chamber syringes are highly efficient for storing the biological components that are unable to retain their stability for a longer period. Moreover, the growing penetration of lyophilized drugs worldwide is likely to raise the demand for these syringes during the forecast period.
Contract Research & Manufacturing Organizations Segment to Witness Accelerated Growth
Based on end-user, the market has been categorized into pharmaceutical & biotechnology companies, contract research & manufacturing organizations, and others. Among them, the pharmaceutical & biotechnology companies segment captured a major prefilled syringes market share. The fast-expanding pharmaceutical companies all over the globe are majorly engaged in biologics, vaccines, and biosimilars. These companies have increased their demand for new drug delivery systems, such as syringes, that are prescribed with a unit dose of medication for better patient compliance. Moreover, a growing number of early-stage, well-funded biotech companies focused on drug discovery and development is likely to boost the demand for these syringes for the effective delivery of drugs. This rise in the demand for innovative injectable drug delivery systems is likely to boost the pharmaceutical & biotechnology companies segment growth during the forecast period.
Contract research & manufacturing organizations segment is likely to expand at a significant rate during the forecast period owing to the presence of innovative technologies offering filling services.
Europe Prefilled Syringes Market Size, 2019 (USD Billion)
To get more information on the regional analysis of this market, Request a Free sample
Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among them, Europe dominated the market and accounted for USD 1.93 billion in 2019. The increasing number of patients using biologics as treatment options for chronic diseases and strong adoption of technologically advanced delivery methods for self-injection of drugs are the major factors likely to boost the demand for pre-fillable syringes in Europe. In addition to that, the presence of key players engaged in the development of pre-fillable syringes in Europe is likely to boost the market growth. For instance, in October 2018, Fresenius Kabi announced the launch of a new prefilled syringe of palonosetron hydrochloride.
North America is likely to hold the second-largest market share after Europe owing to the rise in several chronic diseases such as diabetes and rheumatoid arthritis, which is likely to enhance the demand for prolonged drug administration at an accurate dosage. Growing product launches and growing presence of leading players with strong distribution networks are likely to boost the market growth in North America. The market in Asia-Pacific is likely to witness fast-paced growth during the forecast period, majorly owing to the increasing prevalence of chronic diseases, rise in usage of these syringes, and rapidly growing patient population.
Moreover, rising awareness regarding innovations in these syringes and significant growth in contract manufacturing companies outsourcing packaging & filling services are likely to play a pivotal role in boosting the market growth in Asia Pacific region.
Latin America and Middle East & Africa are likely to experience slow growth in this market owing to the lower awareness about the innovative products and slow penetration of the market in these regions.
Strong Product Offerings by Key Market Players to Propel the Prefilled Syringes Replacement Industry Growth
BD, Gerresheimer AG, SCHOTT AG, and West Pharmaceutical Services Inc. are the leading players in this market with a strong brand presence combined with a wide range of product offerings. These players are likely to continue their dominance and generate significant revenue in the forthcoming years. Dominance is attributable to the robust research activities and continuous investments in innovative product development for the launch of a cost-effective and highly effective parenteral drug delivery system. Moreover, a strong focus on strategic partnerships with other players is likely to support the expansion of their footprints in the global market. For instance, in September 2019, Gerresheimer AG launched Gx RTF ClearJect polymer needle syringe, 2.25 ml to expand its range of prefillable polymer syringes.
The prefilled syringes market report provides detailed information regarding various insights into the market. Some of them are growth drivers, restraints, competitive landscape, regional analysis, and challenges. It further offers an analytical depiction of the market trends and estimations to illustrate the forthcoming investment opportunities. The market is quantitatively analyzed from 2015 to 2026 to provide the financial competency of the market. The information gathered in the report has been taken from several primary and secondary sources.
To gain extensive insights into the market, Request for Customization
Value (USD Billion)
By Closing system
Fortune Business Insights says that the global market size was USD 4.76 billion in 2019 and is expected to reach USD 10.57 billion by 2027.
In 2019, the European market stood at USD 1.93billion.
Growing at a CAGR of 10.5%, the market will exhibit steady growth in the forecast period (2020-2027).
The glass segment is expected to be the leading segment by material in this market during the forecast period.
Rising prevalence of chronic disease diseases combined with increasing demand for biologics as treatment options, increasing awareness of advanced products, and growing product launches are the key factors driving the growth of the market.
BD, Gerresheimer AG, SCHOTT AG, and West Pharmaceutical Services Inc., are the top players in the market
Europe dominated the market share in 2019.
Contract Research & Manufacturing Organizations segment in the end-user category is expected to drive market.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry